U01.17.006 Menkes disease U01.17.006 Summary: Explore the molecular basis of "Kinky Hair Disease." Understand how impaired copper transport leads to secondary collagen defects, neurodegeneration, and growth failure.

Menkes Disease: The Copper Absorption Crisis
#USMLEStep1 #MedEd #Biochemistry #MenkesDisease #CopperDeficiency #KinkyHair #Genetics #Step1Prep #HighYield #MedSchool #Pediatrics #Metabolism #Neurology #FutureDoctor #StudyGram #MedTwitter #Anki #BoardExams #MedicalStudent #FirstAid #MedicalSchool #Pre

FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease | NeurologyLive - Clinical Neurology News and Neurology Expert Insights The FDA approved Sentynl Therapeutics’ copper histidinate for the treatment of pediatric Menkes disease, a rare genetic neurodegenerative disorder, following an earlier complete response letter.

🧬 #FDA approves Zycubo—the FIRST treatment for pediatric Menkes disease!

💉 Subcutaneous copper histidinate boosts survival, especially when started in the first 4 weeks of life. What could newborn screening change? 👶✨

Read more: www.neurologylive.com/view/fda-app...
#MenkesDisease #FDAApproval

U01.01.036 Menkes disease Analyze the question stem by focusing on key clinical clues: developmental delay, hypotonia, seizures, and sparse hypopigmented hair in an infant. Note the low serum copper and mutation in a copper-transporting ATPase — these indicate Menkes disease. Next, recall which copper-dependent enzymes are affected and determine which one explains the connective tissue and neurological findings.

Master Menkes disease — its copper transport defect, enzyme involvement, and clinical presentation.
#MenkesDisease #CopperMetabolism #Genetics #Pediatrics #USMLE